Related news from
Thu, 25 Apr 2024 21:25:06 +0000	ResMed (RMD) Q3 Earnings and Revenues Surpass Estimates ResMed (RMD) delivered earnings and revenue surprises of 10.94% and 1.90%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Fri, 12 Apr 2024 15:00:00 +0000	Baxter's (BAX) New Injectables Aid Its Pharmaceutical Portfolio Baxter (BAX) unveils its five injectable products, which strengthen its emphasis on unique products and expand the pharmaceutical portfolio of the business in important therapeutic areas.
Fri, 12 Apr 2024 12:29:00 +0000	Comfort Systems USA and Boeing have been highlighted as Zacks Bull and Bear of the Day Comfort Systems USA and Boeing are part of the Zacks Bull and Bear of the Day article.
Thu, 11 Apr 2024 13:35:00 +0000	3 Medical Device Stocks With Solid Dividend Yield: CAH & Others Here we discuss three medical device stocks, Cardinal Health (CAH), Baxter International (BAX) and Fresenius Medical Care (FMS), with a solid five-year dividend growth history.
Thu, 11 Apr 2024 12:30:00 +0000	Baxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S. DEERFIELD, Ill., April 11, 2024--Baxter International Inc. (NYSE:BAX), a global leader in injectables, anesthesia and drug compounding, announced the continued expansion of its Pharmaceuticals portfolio with five injectable product launches in the U.S.
Wed, 10 Apr 2024 20:15:00 +0000	Baxter to Host First-Quarter 2024 Financial Results Conference Call for Investors DEERFIELD, Ill., April 10, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its first-quarter 2024 financial results on Thursday, May 2, 2024 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I215737 to pre-register for the call and receive the call information.
Wed, 10 Apr 2024 15:58:00 +0000	Reasons to Hold Baxter International (BAX) in Your Portfolio Baxter International's (BAX) robust growth across all geographies, along with transformational initiatives, raises optimism.
Wed, 10 Apr 2024 14:00:02 +0000	Baxter Is Deeply Undervalued The company is undergoing a transformation to a focused health care player
Fri, 05 Apr 2024 11:22:39 +0000	Shareholders in Baxter International (NYSE:BAX) are in the red if they invested three years ago For many investors, the main point of stock picking is to generate higher returns than the overall market. But if you...
Tue, 02 Apr 2024 16:08:00 +0000	Baxter's (BAX) Latest FDA Approval to Boost Infusion Therapy Baxter's (BAX) Novum IQ Infusion Platform is likely to help enhance patient safety and efficiency for clinicians following the FDA's clearance.
Mon, 01 Apr 2024 11:15:00 +0000	Baxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy DEERFIELD, Ill., April 01, 2024--Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Novum IQ large volume infusion pump (LVP) with Dose IQ Safety Software. Adding LVP modality to the Novum IQ Infusion Platform – which includes Baxter’s syringe infusion pump (SYR) with Dose IQ Safety Software, powered by the IQ Enterprise Connectivity Suite – enables clinicians to utiliz
Wed, 27 Mar 2024 13:00:00 +0000	Baxter to Host Annual Meeting of Stockholders in Virtual Format DEERFIELD, Ill., March 27, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host its Annual Meeting of Stockholders (the 2024 Annual Meeting) in a virtual format on Tuesday, May 7, 2024 at 9 a.m., Central Time, as disclosed in Baxter’s proxy statement for the 2024 Annual Meeting. Online access to the 2024 Annual Meeting will begin at 8:45 a.m., Central Time. Stockholders will not be able to attend the 2024 Annual Meeting in person. The virtual format provides a convenien
Tue, 26 Mar 2024 21:00:55 +0000	Don't 'run away' from tech, but do broaden out: Strategist Yahoo Finance Live revisits the calls made at the end of last year to see which hold up and which are in need of repositioning. Laffer Tengler Investments CEO & CIO Nancy Tengler and Great Hill Capital Chairman and Managing Member Thomas Hayes join Yahoo Finance to revisit and update last year's calls. Hayes outlines his market strategy amid a surging market: "We've been publicly bullish nonstop for a year and a half, and we've recently become more cautious. We're up 17 out of the last 21 weeks. No 2% pullback in the last 100 trading days. So, in recent weeks, we put on a 2% hedge: 1% put spreads on the S&P, 1% put spreads on the semiconductor index, and 98% long. So if we're right, those have an expected value of 5x each." Tengler addresses risks on her radar: "We started broadening out the portfolio, really to have the improvement in some of the names that we've seen in healthcare, financials, some of the more cyclical names...But my biggest concern is that the Fed seems to be, I guess, walking away from their data dependence, and I'll put quotes around that, that they've had in the past. And it seems they're determined to cut. We've drawn an analogy to the 90s. We think you can have higher inflation, but not materially higher. So that's my worry, that we get a surge in inflation because the Fed is too easy." For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Nicholas Jacobino
Wed, 13 Mar 2024 12:21:45 +0000	Should You Hold Baxter International (BAX)? Artisan Partners, an investment management company, released its “Artisan Value Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. US Treasury yields saw a significant decline towards the end of 2023, which led to a massive surge in the last two months of the year for US stocks. The fund’s […]
Thu, 07 Mar 2024 04:50:10 +0000	Baxter to close Massachusetts site, lay off 59 people News of the cuts comes 13 months after the company outlined plans to eliminate 3,000 positions.
Tue, 05 Mar 2024 22:00:44 +0000	Insider Sell: EVP, Chief HR Officer Jeanne Mason Sells 64,488 Shares of Baxter International ... Jeanne Mason, Executive Vice President and Chief Human Resources Officer, has sold 64,488 shares of Baxter International Inc (NYSE:BAX) on March 1, 2024, according to a recent SEC Filing.
Mon, 04 Mar 2024 11:19:00 +0000	Baxter considers selling kidney care unit to private equity The company expects to divest its largest segment, whether through a spinoff or a sale, in the second half of the year.
Thu, 29 Feb 2024 21:15:00 +0000	Baxter to Present at Raymond James 45th Annual Institutional Investors Conference DEERFIELD, Ill., February 29, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Raymond James 45th Annual Institutional Investors Conference on Monday, March 4, 2024. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 4:00 p.m. Eastern Time.
Sat, 24 Feb 2024 12:27:32 +0000	It Might Not Be A Great Idea To Buy Baxter International Inc. (NYSE:BAX) For Its Next Dividend Baxter International Inc. ( NYSE:BAX ) is about to trade ex-dividend in the next four days. The ex-dividend date is one...
Fri, 23 Feb 2024 10:43:17 +0000	20 Fastest Growing Biotech Companies in the US In this article, we will be taking a look at the 20 fastest growing biotech companies in the US. If you are not interested in learning about the landscape of biotech companies, head straight to the 5 Fastest Growing Biotech Companies In The US. The biotechnology sector in the United States is witnessing a surge […]